Action Summary | The Board proposes to amend 18VAC105-20-47 to add cholinergic agonists to the TPA formulary in the category of a Schedule VI topically administered medication. At its meeting on February 11, 2022, the TPA Formulary Committee approved the amendment. A public hearing will be conducted on March 18, 2022 prior to the adoption of a final regulation. |
Chapters Affected | Only affects this chapter. |
Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: ยง 2.2-4002(14). |
RIS Project | Yes [7092] |
New Periodic Review | This action will not be used to conduct a new periodic review. |
Name / Title: | Leslie L. Knachel / Executive Director |
Address: |
9960 Mayland Drive Suite 300 Henrico, VA 23233 |
Email Address: | leslie.knachel@dhp.virginia.gov |
Phone: | (804)597-4130 FAX: (804)527-4471 TDD: ()- |